Depressive and Anxiety Disorders in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Bai, Ru ^a   Liu, Shuang ^a   Zhao, Yueyin ^a   Cheng, Yuqi ^a   Li, Shu ^a   Lai, Aiyun ^a   Xie, Zhongqi ^a   Xu, Xinyu ^a   Lu, Zhaoping ^a   Xu, Jian ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE DERIVATIVE; GLUCOCORTICOID; HYDROXYCHLOROQUINE;

ADOLESCENT; ADULT; ALOPECIA; ANXIETY DISORDER; ARTICLE; BRAIN DAMAGE; CHILD; DEPRESSION; DISEASE ACTIVITY; EMOTIONAL DISORDER; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; ANXIETY DISORDERS; CHINA; COMPLICATION; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PHENOTYPE; PSYCHOLOGY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY DISORDERS; AUTOANTIBODIES; CHINA; DEPRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84991681952     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/2829018     Document Type: Article

References (40)

1. R. Omdal, B. Selseth, N. E. Kløw, G. Husby, and S. I. Mellgren, "Clinical neurological, electrophysiological, and cerebral CT scan findings in systemic lupus erythematosus, " Scandinavian Journal of Rheumatology, vol. 18, no. 5, pp. 283-289, 1989.
2. B. Diamond and B. Volpe, "On the track of neuropsychiatric lupus, " Arthritis & Rheumatism, vol. 48, no. 10, pp. 2710-2712, 2003.
3. J. G. Hanly, G. McCurdy, L. Fougere, J.-A. Douglas, and K. Thompson, "Neuropsychiatric events in systemic lupus erythematosus: Attribution and clinical significance, " The Journal of Rheumatology, vol. 31, no. 11, pp. 2156-2162, 2004.
4. D. Hermosillo-Romo and R. L. Brey, "Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE), " Best Practice & Research: Clinical Rheumatology, vol. 16, no. 2, pp. 229-244, 2002.
5. E. J. Philip, H. Lindner, and L. Lederman, "Confidence in medical care linked to depression in lupus sufferers, " Journal of Allied Health, vol. 38, no. 2, pp. 106-112, 2009.
6. F. G. Nery, E. F. Borba, V. S. T. Viana et al., "Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies, " Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 32, no. 3, pp. 695-700, 2008.
7. G. Marian, E. A. Nica, B. E. Ionescu, and D. G. Carlogea, "Depression as an initial feature of systemic lupus erythematosus? A case report, " Journal ofMedicine and Life, vol. 3, no. 2, pp. 183-185, 2010.
8. H.-X. Gao, S. R. Campbell, M.-H. Cui et al., "Depression is an early disease manifestation in lupus-prone MRL/lpr mice, " Journal of Neuroimmunology, vol. 207, no. 1-2, pp. 45-56, 2009.
9. E. Schattner, G. Shahar, S. Lerman, and M. A. Shakra, "Depression in systemic lupus erythematosus: The key role of illness intrusiveness and concealment of symptoms, " Psychiatry, vol. 73, no. 4, pp. 329-340, 2010.
10. M. Hamilton, "A rating scale for depression, " Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, pp. 56-62, 1960.
11. M. Hamilton, "The assessment of anxiety states by rating, " The British Journal of Medical Psychology, vol. 32, no. 1, pp. 50-55, 1959.
12. C. Bombardier, D. D. Gladman, M. B. Urowitz et al., "Derivation of the SLEDAI: A disease activity index for lupus patients, " Arthritis and Rheumatism, vol. 35, no. 6, pp. 630-640, 1992.
13. The American College of Rheumatology, "Nomenclature and case definitions for neuropsychiatric lupus syndromes, " Arthritis & Rheumatism, vol. 42, no. 4, pp. 599-608, 1999.
14. M. Valencia-Flores, M. Resendiz, V. A. Castaño et al., "Objective and subjective sleep disturbances in patients with systemic lupus erythematosus, " Arthritis & Rheumatism, vol. 42, no. 10, pp. 2189-2193, 1999.
15. H. Ainiala, J. Loukkola, J. Peltola, M. Korpela, and A. Hietaharju, "The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus, " Neurology, vol. 57, no. 3, pp. 496-500, 2001.
16. F. Uguz, A. Kucuk, E. Cicek, F. Kayhan, and R. Tunc, "Mood, anxiety and personality disorders in patients with systemic lupus erythematosus, " Comprehensive Psychiatry, vol. 54, no. 4, pp. 341-345, 2013.
17. L. J. Julian, C. Tonner, E. Yelin et al., "Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus, " Arthritis Care & Research, vol. 63, no. 4, pp. 542-549, 2011.
18. F. G. Nery, E. F. Borba, J. P. Hatch, J. C. Soares, E. Bonfá, and F. L. Neto, "Major depressive disorder and disease activity in systemic lupus erythematosus, " Comprehensive Psychiatry, vol. 48, no. 1, pp. 14-19, 2007.
19. J. G. Hanly, L. Su, M. B. Urowitz et al., "Mood disorders in systemic lupus erythematosus: results from an international inception cohort study, " Arthritis & Rheumatology, vol. 67, no. 7, pp. 1837-1847, 2015.
20. X. Huang, L. S. Magder, and M. Petri, "Predictors of incident depression in systemic lupus erythematosus, " The Journal of Rheumatology, vol. 41, no. 9, pp. 1823-1833, 2014.
21. E. A. Bachen, M. A. Chesney, and L. A. Criswell, "Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus, " Arthritis Care and Research, vol. 61, no. 6, pp. 822-829, 2009.
22. L. Palagini, M. Mosca, C. Tani, A. Gemignani, M. Mauri, and S. Bombardieri, "Depression and systemic lupus erythematosus: A systematic review, " Lupus, vol. 22, no. 5, pp. 409-416, 2013.
23. D. Carmona-Fernandes, M. J. Santos, H. Canhão, and J. E. Fonseca, "Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile, "BMCMedicine, vol. 11, no. 1, article 98, 2013.
24. M. Karimifar, I. Sharifi, and K. Shafiey, "Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus, " Journal of Research in Medical Sciences, vol. 18, no. 10, pp. 860-864, 2013.
25. A. M. Abdel-Nasser, R. M. Ghaleb, J. A. Mahmoud, W. Khairy, and R. M. Mahmoud, "Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus, " Clinical Rheumatology, vol. 27, no. 11, pp. 1377-1385, 2008.
26. C. Johanet, C. André, J. Sibilia et al., "Clinical significance of antiribosomal antibodies. Study Group on Autoimmunity (GEAI), " La Revue de Médecine Interne, vol. 21, no. 6, pp. 510-516, 2000.
27. S. G. West, W. Emlen, M. H. Wener, and B. L. Kotzin, "Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests, " The American Journal of Medicine, vol. 99, no. 2, pp. 153-163, 1995.
28. S. Hirohata, Y. Arinuma, M. Takayama, and T. Yoshio, "Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus, " Arthritis Research & Therapy, vol. 9, no. 3, article R44, 2007.
29. T. Yoshio, D. Hirata, K. Onda, H. Nara, and S. Minota, "Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus, " Journal of Rheumatology, vol. 32, no. 1, pp. 34-39, 2005.
30. A. Katzav, T. Ben-Ziv, J. Chapman, M. Blank, M. Reichlin, and Y. Shoenfeld, "Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression), " Journal of Autoimmunity, vol. 31, no. 4, pp. 393-398, 2008.
31. S. Kivity, G. Tsarfaty, N. Agmon-Levin et al., "Abnormal olfactory function demonstrated bymanganese-enhanced MRI in mice with experimental neuropsychiatric lupus: Annals of the New York Academy of Sciences, " Annals of the New York Academy of Sciences, vol. 1193, pp. 70-77, 2010.
32. A. Katzav, T. Ben-Ziv, M. Blank, C. G. Pick, Y. Shoenfeld, and J. Chapman, "Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice, " Journal of Neuroimmunology, vol. 272, no. 1-2, pp. 10-15, 2014.
33. N. Agmon-Levin, B. Gilburd, S. Kivity et al., "Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays, " The Israel Medical Association Journal, vol. 11, no. 7, pp. 403-406, 2009.
34. S. Haddouk, S. Marzouk, M. Jallouli et al., "Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus, " Rheumatology, vol. 48, no. 8, pp. 953-957, 2009.
35. R. A. Iseme, M. McEvoy, B. Kelly, L. Agnew, J. Attia, and F. R. Walker, "Autoantibodies and depression: evidence for a causal link?" Neuroscience and Biobehavioral Reviews, vol. 40, pp. 62-79, 2014.
36. F. C. Arnett, J. D. Reveille, H. M. Moutsopoulos, L. Georgescu, and K. B. Elkon, "Ribosomal P autoantibodies in systemic lupus erythematosus: frequencies in different ethnic groups and clinical and immunogenetic associations, " Arthritis and Rheumatism, vol. 39, no. 11, pp. 1833-1839, 1996.
37. H. Aldar, A. T. Lapa, B. Bellini et al., "Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus, " Lupus, vol. 21, no. 11, pp. 1225-1231, 2012.
38. T. Ebert, J. Chapman, and Y. Shoenfeld, "Anti-ribosomal Pprotein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?" Lupus, vol. 14, no. 8, pp. 571-575, 2005.
39. E. Jarpa, M. Babul, J. Calderón et al., "Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity, " Lupus, vol. 20, no. 1, pp. 58-66, 2011.
40. F. Conti, C. Alessandri, D. Bompane et al., "Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: A role for anti-endothelial-cell antibodies, " Arthritis Research &Therapy, vol. 6, no. 4, pp. R366-R372, 2004.